Registered Tanzania · TMDA

Hidrasec Infants 10 mg Granules

Racecadotril 10 mg

TZ 14 H 0271 Granules for Oral suspension INN generic

What it does

Racecadotril is a medication used to treat acute diarrhea, helping to reduce the number of watery stools.

Commonly used for: acute diarrhea, watery stools

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TZ 14 H 0271
Registration date
2024-09-17
Expiry date
2029-09-16
Status
Registered/Compliant
Active ingredient
Racecadotril 10 mg
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Sophartex
Country of origin
FRANCE
Manufacturer location
21 Rue du Pressoir, 28500 Vernouillet, France

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-03-11 23:55:05 · updated 2026-09-24 03:00:47

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About this medicine

Racecadotril is a medication used to treat acute diarrhea, helping to reduce the number of watery stools.

What it treats

  • acute diarrhea
  • watery stools

How it works

It works by reducing the amount of fluid in the intestines, which helps to decrease diarrhea.

Who it's for

Racecadotril is suitable for adults and children experiencing sudden diarrhea.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Racecadotril

BNF-referenced

Racecadotril is an antidiarrheal medication that acts as an enkephalinase inhibitor. It is primarily used in the symptomatic treatment of acute diarrhea, reducing the volume and frequency of stools without affecting intestinal motility. Unlike loperamide, racecadotril does not inhibit peristalsis but acts by enhancing the body’s natural defenses against diarrhea.

Indications

  • Acute diarrhea
  • Symptomatic treatment of diarrheal episodes

Dosage

Children: For children aged 3 months to 12 years, the dose is typically 1.5 mg/kg/day in divided doses. For children aged 12 years and older, the adult dosing regimen may be applied. Refer to the BNF for Children for detailed dosing guidelines.

Adults: The usual adult dose is 100 mg three times daily for up to 7 days. The treatment should be continued until diarrhea resolves.

Mechanism of action

Racecadotril is a prodrug that is converted to its active form, thiorphan, which inhibits the enzyme enkephalinase. This inhibition increases the levels of endogenous enkephalins in the gut, leading to a reduction in excessive intestinal secretions and an increase in absorption of fluids and electrolytes, thereby alleviating diarrhea.

Pharmacodynamics

Racecadotril has a rapid onset of action, with its effects seen within 1 hour of administration. It selectively targets enkephalinase and has minimal impact on gut motility, making it effective for treating acute diarrhea without the risk of constipation associated with other antidiarrheal agents.

Pharmacokinetics

After oral administration, racecadotril is rapidly absorbed and its active metabolite, thiorphan, reaches peak plasma concentrations in approximately 1 hour. The elimination half-life is around 3 hours, and it is primarily excreted through urine. The drug does not significantly alter the pharmacokinetics of other medications.

Adverse effects

  • abdominal pain
  • nausea
  • vomiting
  • headache
  • dizziness
  • constipation

Interactions

  • CNS depressants may enhance sedative effects
  • Antidiarrheal agents may mask underlying conditions

Precautions

  • Use with caution in patients with a history of gastrointestinal obstruction
  • Monitor for signs of dehydration in patients with diarrhea
  • Not recommended for use in children under 12 years

Pregnancy

Racecadotril should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as safety has not been established.

Breast-feeding

Lactating mothers should use racecadotril with caution; it is not known whether racecadotril is excreted in human milk.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Capsules
  • Oral suspension
  • Tablets
BNF for Children 2019-2020 p.73 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Racecadotril

PubChem CID 107751

Molecular formula: C21H23NO4S

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.